Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Oral Maxillofac Surg ; 51(3): 314-322, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34090757

ABSTRACT

While Merkel cell carcinoma (MCC) of the head and neck is highly malignant, it remains poorly characterized due to its rarity. The purpose of this study was to examine prognostic factors for overall survival (OS) and disease-specific survival (DSS) in patients with MCC of the head and neck region. The Surveillance, Epidemiology and End Results registry was reviewed for patients diagnosed between 1984 and 2016 with histologically confirmed, primary MCC of the head and neck region. A total of 2818 patients met the inclusion criteria, with a median age at diagnosis of 77 years. At five and 10 years, respectively, the OS was 42.4% and 25.1% and the DSS was 67.9% and 64.1%. Multivariate Cox analysis indicated that predictors of decreased DSS included age at diagnosis ≥75 years, white race, increasing tumor spread, lymph node involvement and either the lip or the scalp/neck as a primary site. When adjusting for the aforementioned factors, tumor depth was not found to be a prognostic factor for DSS. We anticipate these results will help clinicians to counsel patients regarding expectations and potential prognosis.


Subject(s)
Carcinoma, Merkel Cell , Head and Neck Neoplasms , Skin Neoplasms , Carcinoma, Merkel Cell/pathology , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/therapy , Humans , Neoplasm Staging , Prognosis , Retrospective Studies , SEER Program , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...